Header Logo

Connection

Melody Cobleigh to Carcinoma, Bronchogenic

Back to Details
This is a "connection" page, showing publications Melody Cobleigh has written about Carcinoma, Bronchogenic.
Melody Cobleigh
Connection Strength
0.014
Carcinoma, Bronchogenic
  1. Phase II trial of bisantrene for unresectable non-small cell bronchogenic carcinoma: an Illinois Cancer Council study. Cancer Treat Rep. 1983 Sep; 67(9):841-2.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.